FONDAPARINUX IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION – JUSTIFICATION FOR USING AND REAL CLINICAL PRACTICE
Prevention of activation of blood coagulation is a cornerstone of treatment strategies in patients with acute coronary syndrome (ACS). Medications that are used for this purpose help stop building up of blood clots in the area of damaged atherosclerotic plaque and prevent the development or recurren...
Main Author: | A. D. Erlikh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2018-05-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/147 |
Similar Items
-
REVIEW OF RECOMMENDATIONS FOR THE MANAGEMENT OF THE ACUTE CORONARY SYNDROMES IN PATIENTS PRESENTING WITHOUT PERSISTENT ST-SEGMENT ELEVATION (ESC 2015). Part I
by: N. T. Vatutin, et al.
Published: (2016-05-01) -
Regarding the choice of Р2У<sub>12</sub> platelet receptor blocker in the early invasive approach to acute coronary syndrome treatment in patients without indications for long-term anticoagulant use
by: I. S. Yavelov
Published: (2020-12-01) -
Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
by: O. L. Barbarash, et al.
Published: (2021-11-01) -
Modern potential of thrombotic complication prevention among patients with acute coronary syndrome without ST segment elevation in real clinical practice (Part I)
by: T. M. Poponina, et al.
Published: (1970-01-01) -
Optimising the treatment of patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (1970-01-01)